Functional characteristics of heterologously expressed 5-HT receptors

European Journal of Pharmacology

Volumn 334, Issue 1, 1997, Pages 1-23

  Gerhardt, Cindy C ^a   Van Heerikhuizen, Harm ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT receptor; G protein coupled receptor; Signal transduction

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

EVOLUTION; GENE EXPRESSION; INVERTEBRATE; MAMMAL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030774639     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01115-1     Document Type: Article

References (188)

1. Abdel-Baset H., Bozovic V., Szyf M., Albert P.R. Conditional transformation mediated via a pertussis toxin-sensitive receptor signalling pathway. Mol. Endocrinol. 6:1992;730-740.
2. Abdul M., Anezinis P.E., Logothetis C.J., Hoosein N.M. Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res. 14:1994;1215-1220.
3. Adham N., Borden L.A., Schechter L.E., Gustafson E.L., Cochran T.L., Vaysse P.J., Weinshank R.L., Branchek T.A. Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways. Naunyn Schmiedebergs Arch. Pharmacol. 348:1993;566-575.
4. Adham N., Kao H.R., Schechter L.E., Bard J., Olsen M., Urquhart D., Durkin M., Hartig P.R., Weinshank R.L., Branchek T.A. Cloning of another human serotonin receptor (5-HT1F)-A 5th 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. USA. 90:1993;408-412.
5. Adham N., Romanienko P., Hartig P., Weinshank R.L., Branchek T. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor. Mol. Pharmacol. 41:1992;1-7.
6. Adham N., Vaysse P.J., Weinshank R.L., Branchek T.A. The cloned human 5-HT1E receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells. Neuropharmacology. 33:1994;403-410.
7. Akiyoshi J., Nishizono A., Yamada K., Nagayama H., Mifune K., Fujii I. Rapid desensitization of serotonin 5-HT2C receptor stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors. J. Neurochem. 64:1995;2473-2479.
8. Albert P.R., Zhou Q.Y., van Tol H.H., Bunzow J.R., Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J. Biol. Chem. 265:1990;5825-5832.
9. Almaula N., Ebersole B.J., Zhang D., Weinstein H., Sealfon S.C. Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. J. Biol. Chem. 271:1996;14672-14675.
10. Amlaiky N., Ramboz S., Boschert U., Plassat J.L., Hen R. Isolation of a mouse '5HT1E-like' serotonin receptor expressed predominantly in hippocampus. J. Biol. Chem. 267:1992;19761-19764.
11. Apud J.A., Grayson D.R., De E.E., Costa E. Pharmacological characterization of regulation of phosphoinositide metabolism by recombinant 5-HT2 receptors of the rat. Neuropharmacology. 31:1992;1-8.
12. Bach A.W., Unger L., Sprengel R., Mengod G., Palacios J., Seeburg P.H., Voigt M.M. Structure functional expression and spatial distribution of a cloned cDNA encoding a rat 5-HT1D-like receptor. J. Recept. Res. 13:1993;479-502.
13. Bach M., Sander P., Haase W., Reilander H. Pharmacological and biochemical characterization of the mouse 5HT(5A) serotonin receptor heterologously produced in the yeast Saccharomyces cerevisiae. Receptors Channels. 4:1996;129-139.
14. Backstrom J.R., Westphal R.S., Canton H., Sanders-Bush E. Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides. Brain Res. Mol. Brain Res. 33:1995;311-318.
15. Bard J.A., Zgombick J., Adham N., Vaysse P., Branchek T.A., Weinshank R.L. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268:1993;23422-23426.
16. Barker E.L., Westphal R.S., Schmidt D., Sanders-Bush E. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269:1994;11687-11690.
17. Berg K.A., Clarke W.P., Chen Y., Ebersole B.J., McKay R.D., Maayani S. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. Mol. Pharmacol. 45:1994;826-836.
18. Berg K.A., Clarke W.P., Sailstad C., Saltzman A., Maayani S. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol. 46:1994;477-484.
19. Berg K.A., Maayani S., Clarke W.P. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. Mol. Pharmacol. 50:1996;1017-1023.
20. Berry S.A., Shah M.C., Khan N., Roth B.L. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol. Pharmacol. 50:1996;306-313.
21. Bertin B., Freissmuth M., Breyer R.M., Schutz W., Strosberg A.D., Marullo S. Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J. Biol. Chem. 267:1992;8200-8206.
22. Boddeke H.W., Fargin A., Raymond J.R., Schoeffter P., Hoyer D. Agonist/antagonist interactions with cloned human 5-HT1A receptors: Variations in intrinsic activity studied in transfected HeLa cells. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;257-263.
23. Boddeke H.W., Hoffman B.J., Palacios J.M., Hoyer D. Calcineurin inhibits desensitization of cloned rat 5-HT1C receptors. Naunyn Schmiedebergs Arch. Pharmacol. 348:1993;221-224.
24. Boddeke H.W., Hoffman B.J., Palacios J.M., Knot H., Hoyer D. Characterization of functional responses in A9 cells transfected with cloned rat 5-HT1C receptors. Naunyn Schmiedebergs Arch. Pharmacol. 347:1993;119-124.
25. Bonhaus D.W., Bach C., Desouza A., Salazar F.H.R., Matsuoka B.D., Zuppan P., Chan H.W., Eglen R.M. The pharmacology and distribution of human 5-hydroxytryptamine(2B) (5-HT2B) receptor gene products: Comparison with 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 115:1995;622-628.
26. Bourson A., Borroni E., Austin R.H., Monsma F.J.j., Sleight A.J. Determination of the role of the 5-HT6 receptor in the rat brain: A study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 274:1995;173-180.
27. Bradley P.B., Engel G., Feniuk W., Fozard J.R., Humphrey P.P.A., Middlemiss D.N., Mylecharane E.J., Richardson B.P., Saxena P.R. Proposals for the classification and nomenclature of functional receptors for 5-hyroxytryptamine. Neuropharmacology. 25:1986;563-576.
28. 3H ]-ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor Mol. Pharmacol. 38:1990;604-609.
29. Briggs C.A., Pollock N.J., Frail D.E., Paxson C.L., Rakowski R.F., Kang C.H., Kebabian J.W. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br. J. Pharmacol. 104:1991;1038-1044.
30. Buck F., Meyerhof W., Werr H., Richter D. Characterization of N- and C-terminal deletion mutants of the rat serotonin HT2 receptor in Xenopus laevis oocytes. Biochem. Biophys. Res. Commun. 178:1991;1421-1428.
31. Canton H., Emeson R.B., Barker E.L., Backstrom J.R., Lu J.T., Chang M.S., Sanders B.E. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol. Pharmacol. 50:1996;799-807.
32. Cerutis D.R., Hass N.A., Iversen L.J., Bylund D.B. The cloning and expression of an OK cell cDNA encoding a 5- hydroxytryptamine1B receptor. Mol. Pharmacol. 45:1994;20-28.
33. Chambard J.C., Van Obberghen-Schilling E., Haslam R.J., Vouret V., Pouyssegur J. Chinese hamster serotonin (5-HT) type 2 receptor cDNA sequence. Nucleic Acids Res. 18:1990;5282.
34. Chanda P.K., Minchin M.C., Davis A.R., Greenberg L., Reilly Y., McGregor W.H., Bhat R., Lubeck M.D., Mizutani S., Hung P.P. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. Mol. Pharmacol. 43:1993;516-520.
35. Charest A., Wainer B.H., Albert P.R. Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line. J. Neurosci. 13:1993;5164-5171.
36. Chen K., Yang W., Grimsby J., Shih J.C. The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Mol. Brain Res. 14:1992;20-26.
37. Chen Y., Baez M., Yu L. Functional coupling of the 5-HT2C serotonin receptor to G proteins in Xenopus oocytes. Neurosci. Lett. 179:1994;100-102.
38. Choi D.S., Birraux G., Launay J.M., Maroteaux L. The human serotonin 5-HT2B receptor: Pharmacological link between 5-HT2 and 5-HT1D receptors. FEBS Lett. 352:1994;393-399.
39. 3H ]ketanserine binding to 5-HT2 receptors Mol. Pharmacol. 43:1993;755-761.
40. Choudhary M.S., Sachs N., Uluer A., Glennon R.A., Westkaemper R.B., Roth B.L. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: Ergolines require an aromatic residue at position 340 for high affinity binding. Mol. Pharmacol. 47:1995;450-457.
41. Colas, J.-F., Choi, D.-S., Launay, J.-M., Maroteaux, L., in press. Evolutionary conservation of the 5-HT2B receptors. Ann. N. Y. Acad. Sci.
42. Colas J.F., Launay J.M., Kellermann O., Rosay P., Maroteaux L. Drosophila 5-HT2 serotonin receptor: Coexpression with fushi-tarazu during segmentation. Proc. Natl. Acad. Sci. USA. 92:1995;5441-5445.
43. Conner D.A., Mansour T.E. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: A novel 5-hydroxytryptamine receptor. Mol. Pharmacol. 37:1990;742-751.
44. Cook E.H. Jr., Fletcher K.E., Wainwright M., Marks N., Yan S.Y., Leventhal B.L. Primary structure of the human platelet serotonin 5-HT2A receptor: Identify with frontal cortex serotonin 5-HT2A receptor. J. Neurochem. 63:1994;465-469.
45. Demchyshyn L., Sunahara R.K., Miller K., Teitler M., Hoffman B.J., Kennedy J.L., Seeman P., Van Tol H.H., Niznik H.B. A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6. Proc. Natl. Acad. Sci. USA. 89:1992;5522-5526.
46. Eglen R.M., Jasper J.R., Chang D.J., Martin G.R. The 5-HT7 receptor: Orphan found. Trends Pharmacol. Sci. 18:1997;104-107.
47. Erlander M.G., Lovenberg T.W., Baron B.M., de Lecea L., Danielson P.E., Racke M., Slone A.L., Siegel B.W., Foye P.E., Cannon K.et al. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. USA. 90:1993;3452-3456.
48. Fargin A., Raymond J.R., Lohse M.J., Kobilka B.K., Caron M.G., Lefkowitz R.J. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature. 335:1988;358-360.
49. Fargin A., Raymond J.R., Regan J.W., Cotecchia S., Lefkowitz R.J., Caron M.G. Effector coupling mechanisms of the cloned 5-HT1A receptor. J. Biol. Chem. 264:1989;14848-14852.
50. Fargin A., Yamamoto K., Cotecchia S., Goldsmith P.K., Spiegel A.M., Lapetina E.G., Caron M.G., Lefkowitz R.J. Dual coupling of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein. Cell. Signal. 3:1991;547-557.
51. Felder C.C., Kanterman R.Y., Ma A.L., Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotoin receptor that is independent of inositolphospholipid hydrolysis. Neurobiol. 87:1990;2187-2191.
52. Fenrick R., Pou C., Beliveau M., Fargin A. The human 5-hydroxytryptamine 1A receptor differentially modulates phospholipase C and adenylyl cyclase activities. Gen. Pharmacol. 27:1996;263-268.
53. Foguet M., Hoyer D., Pardo L.A., Parekh A., Kluxen F.W., Kalkman H.O., Stuhmer W., Lubbert H. Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J. 11:1992;3481-3487.
54. Foguet M., Nguyen H., Le H., Lubbert H. Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. Neuroreport. 3:1992;345-348.
55. Fujiwara Y., Tomita H., Hikiji M., Kashihara K., Otsuki S., Ohnuki T., Hamagishi Y., Oki T., Sora I., Roeske W.R.et al. Characterization of a cloned rat serotonin 5-HT1A receptor expressed in the HeLa cell line. Life Sci. 52:1993;949-958.
56. Garnovskaya M.N., Nebigil C.G., Arthur J.M., Spurney R.F., Raymond J.R. 5-hydroxytryptamine(2A) receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation. Mol. Pharmacol. 48:1995;230-237.
57. Gerald C., Adham N., Kao H.T., Olsen M.A., Laz T.M., Schechter L.E., Bard J.A., Vaysse P.J.J., Hartig P.R., Branchek T.A., Weinshank R.L. The 5-HT4 receptor: Molecular cloning and pharmacological characterization of two splice variants. EMBO J. 14:1995;2806-2815.
58. Gerhardt C.C., Leysen J.E., Planta R.J., Vreugdenhil E., Van Heerikhuizen H. Functional characterization of a 5-HT2 receptor cDNA cloned from Lymnaea stagnalis. Eur. J. Pharmacol. 311:1996;249-258.
59. Grotewiel M.S., Sanders-Bush E. Regulation of serotonin(2A) receptors in heterologous expression systems. J. Neurochem. 63:1994;1255-1260.
60. Guan X.M., Peroutka S.J., Kobilka B.K. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. Mol. Pharmacol. 41:1992;695-698.
61. Gudermann T., Levy F.O., Birnbaumer M., Birnbaumer L., Kaumann A.J. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor. Mol. Pharmacol. 43:1993;412-418.
62. Hamblin M.W., McGuffin R.W., Metcalf M.A., Dorsa D.M., Merchant K.M. Distinct 5-HT1B and 5-HT1D reotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors. Mol. Cell. Neurosci. 3:1992;578-587.
63. Hamblin M.W., Metcalf M.A. Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol. Pharmacol. 40:1991;143-148.
64. Hamblin M.W., Metcalf M.A., McGuffin R.W., Karpells S. Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: A homologue of the rat 5-HT1B receptor with 5-HT1D- like pharmacological specificity. Biochem. Biophys. Res. Commun. 184:1992;752-759.
65. Hamel E., Fan E., Linville D., Ting V., Villemure J.G., Chia L.S. Expression of mRNA for the serotonin 5-hydroxytryptamine1D receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44:1993;242-246.
66. Hartig P.R., Branchek T.A., Weinshank R.L. A subfamily of 5-HT1D receptor genes. Trends Pharmacol. Sci. 13:1992;152-159.
67. Hartig P.R., Hoyer D., Humphrey P.P.A., Martin G.R. Alignment of receptor nomenclature with the human genome: Classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol. Sci. 17:1996;103-105.
68. 3H ]mesulergine in a clonal 5-hydroxytryptamine1 cell line Brain Res. 584:1992;191-196.
69. Ho B.Y., Karschin A., Branchek T., Davidson N., Lester H.A. The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1A receptor: A site-directed mutation study. FEBS Lett. 312:1992;259-262.
70. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
71. Humphrey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:1993;233-236.
72. Jasper, J.R., To, A.P., Kosaka, A., Eglen, R.M., Chang, D.J., in press. Br. J. Pharmacol.
73. Jin H., Oksenberg D., Ashkenazi A., Peroutka S.J., Duncan A.M., Rozmahel R., Yang Y., Mengod G., Palacios J.M., O'Dowd B.F. Characterization of the human 5-hydroxytryptamine1B receptor. J. Biol. Chem. 267:1992;5735-5738.
74. Johnson M.P., Baez M., Kursar J.D., Nelson D.L. Species differences in 5-HT2A receptors: Cloned pig and rhesus monkey 5-HT2A receptors reveal conserved transmembrane homology to the human rather than rat sequence. Biochim. Biophys. Acta. 1236:1995;201-206.
75. Johnson M.P., Loncharich R.J., Baez M., Nelson D.L. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol. Pharmacol. 45:1994;277-286.
76. Julius D., Huang K.N., Livelli T.J., Axel R., Jessell T.M. The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc. Natl. Acad. Sci. USA. 87:1990;928-932.
77. Julius D., Livelli T.J., Jessel T.M., Axel R. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science. 244:1989;1057-1062.
78. Julius D., MacDermott A.B., Axel R., Jessell T.M. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science. 241:1988;558-564.
79. Kahan C., Julius D., Pouyssegur J., Seuwen K. Effects of 5-HT1C-receptor expression on cell proliferation control in hamster fibroblasts: Serotonin fails to induce a transformed phenotype. Exp. Cell Res. 200:1992;523-527.
80. Kao H.T., Adham N., Olsen M.A., Weinshank R.L., Branchek T.A., Hartig P.R. Site-directed mutagenesis of a single residue changes the binding properties of the serotonin 5-HT2 receptor from a human to a rat pharmacology the serotonin 5-HT2 receptor from a human to a rat pharmacology. FEBS Lett. 307:1992;324-328.
81. Karschin A., Ho B.Y., Labarca C., Elroy-Stein O., Moss B., Davidson N., Lester H.A. Heterologously expressed serotonin 1A receptors couple to muscarinic K+ channels in heart. Proc. Natl. Acad. Sci. USA. 88:1991;5694-5698.
82. Kaumann A.J., Frenken M., Posival H., Brown A.M. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated arteries. Circulation. 90:1994;1141-1153.
83. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J., Caron M.G. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature London. 329:1987;75-79.
84. Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E., Meltzer H.Y., Sibley D.R., Roth B.L., Hamblin M.W. Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem. 66:1996;47-56.
85. Kursar J.D., Nelson D.L., Wainscott D.B., Baez M. Molecular cloning, functional expression and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol. Pharmacol. 46:1994;227-234.
86. Kursar J.D., Nelson D.L., Wainscott D.B., Cohen M.L., Baez M. Molecular cloning, functional expression and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol. Pharmacol. 42:1992;549-557.
87. Labrecque J., Fargin A., Bouvier M., Chidiac P., Dennis M. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol. Pharmacol. 48:1995;150-159.
88. Launay J.M., Birraux G., Bondoux D., Callebert J., Choi D.S., Loric S., Maroteaux L. Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J. Biol. Chem. 271:1996;3141-3147.
89. Leonhardt S., Gorospe E., Hoffman B.J., Teitler M. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. Mol. Pharmacol. 42:1992;328-335.
90. Leonhardt S., Herrick-Davis K., Titeler M. Detection of a novel serotonin receptor subtype (5-HT1E): A fifth 5-H1-like subtype. Proc. Natl. Acad. Sci. USA. 89:1989;5517-5521.
91. Levy F.O., Gudermann T., Birnbaumer M., Kaumann A.J., Birnbaumer L. Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase. FEBS Lett. 296:1992;201-206.
92. Levy F.O., Gudermann T., Perez-Reyes E., Birnbaumer M., Kaumann A.J., Birnbaumer L. Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype. J. Biol. Chem. 267:1992;7553-7562.
93. Li X.C., Giot J.F., Kuhl D., Hen R., Kandel E.R. Cloning and characterization of two related serotonergic receptors from the brain and the reproductive system of Aplysia that activate phospholipase C. J. Neurosci. 15:1995;7585-7591.
94. Libert F., Parmentier M., Lefort A., Dinsart C., Van Sande J., Maenhaut C., Simons M.J., Dumont J.E., Vassart G. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science. 244:1989;569-572.
95. Liu Y.F., Albert P.R. Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A. J. Biol. Chem. 266:1991;23689-23697.
96. Loric S., Launay J.M., Colas J.F., Maroteaux L. New mouse 5-HT2-like receptor. Expression in brain, heart and intestine. FEBS Lett. 312:1992;203-207.
97. Loric S., Maroteaux L., Kellermann O., Launay J.M. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol. Pharmacol. 47:1995;458-466.
98. Lovenberg T.W., Baron B.M., de Lecea L., Miller J.D., Prosser R.A., Rea M.A., Foye P.E., Racke M., Slone A.L., Siegel B.W.et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11:1993;449-458.
99. Lovenberg T.W., Erlander M.G., Baron B.M., Racke M., Slone A.L., Siegel B.W., Craft C.M., Burns J.E., Danielson P.E., Sutcliffe J.G. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Proc. Natl. Acad. Sci. USA. 90:1993;2184-2188.
100. Lubbert H., Hoffman B.J., Snutch T.P., van Dyke T., Levine A.J., Hartig P.R., Lester H.A., Davidson N. cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 84:1987;4332-4336.
101. Lucaites V.L., Nelson D.L., Wainscott D.B., Baez M. Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. Life Sci. 59:1996;1081-1095.
102. Lutz E.M., Mitchell R., Johnson M.S., MacEwan D. Functional expression of 5-HT1c receptor cDNA in COS 7 cells and its influence on protein kinase C. FEBS Lett. 316:1993;228-232.
103. Maenhaut C., Van Sande J., Massart C., Dinsart C., Libert F., Monferini E., Giraldo E., Ladinsky H., Vassart G., Dumont J.E. The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. Biochem. Biophys. Res. Commun. 180:1991;1460-1468.
104. Mangel A.W., Raymond J.R., Fitz J.G. Regulation of high-conductance anion channels by G-proteins and 5-HT1A receptors in CHO cells. Am. J. Physiol. 264:1993;F490-F495.
105. Maroteaux L., Saudou F., Amlaiky N., Boschert U., Plassat J.L., Hen R. Mouse 5HT1B serotonin receptor: Cloning, functional expression and localization in motor control centers. Proc. Natl. Acad. Sci. USA. 89:1992;3020-3024.
106. Massot O., Rousselle J.-C., Fillion M.-P., Grimaldi B., Cloëz-Tayarani I., Fugelli A., Prudhomme N., Seguin L., Rousseau B., Plantefol M., Hen R., Fillion G. 5-Hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with the 5-hydroxytryptamine1B/1D receptors. Mol. Pharmacol. 50:1996;752-762.
107. Matthes H., Boschert U., Amlaiky N., Grailhe R., Plassat J.L., Muscatelli F., Mattei M.G., Hen R. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: Cloning, functional expression and chromosomal localization. Mol. Pharmacol. 43:1993;313-319.
108. - cotransport. Mol. Pharmacol. 45:1994;991-996.
109. McAllister G., Charlesworth A., Snodin C., Beer M.S., Noble A.J., Middlemiss D.N., Iversen L.L., Whiting P. Molecular cloning of a serotonin receptor from human brain (5HT1E): A fifth 5HT1-like subtype. Proc. Natl. Acad. Sci. USA. 89:1992;5517-5521.
110. Metcalf M.A., McGuffin R.W., Hamblin M.W. Conversion of the human 5-HT1D beta serotonin receptor to the rat 5- HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis. Biochem. Pharmacol. 44:1992;1917-1920.
111. Meyerhof W., Obermuller F., Fehr S., Richter D. A novel rat serotonin receptor: Primary structure, pharmacology and expression pattern in distinct brain regions. DNA Cell. Biol. 12:1993;401-409.
112. Middleton J.P., Raymond J.R., Whorton A.R., Dennis V.W. Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in Hela cells. J. Clin. Invest. 86:1990;1799-1805.
113. Monsma F.J. Jr., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43:1993;320-327.
114. Nebigil C.G., Garnovskaya M.N., Casanas S.J., Mulheron J.G., Parker E.M., Gettys T.W., Raymond J.R. Agonist-induced desensitization and phosphorylation of human 5-HT1A receptor expressed in Sf9 insect cells. Biochem. 34:1995;11954-11962.
115. Nelson C.S., Cone R.D., Robbins L.S., Allen C.N., Adelman J.P. Cloning and expression of a 5HT7 receptor from Xenopus laevis. Receptors Channels. 3:1995;61-70.
116. Newman-Tancredi A., Wootton R., Strange P.G. High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells. Biochem. J. 285:1992;933-938.
117. Obosi L.A., Schuette D.G., Europefinner G.N., Beadle D.J., Hen R., King L.A., Bermudez I. Functional characterisation of the Drosophila 5-HTdro1 and 5-HTdro2B serotonin receptors in insect cells: Activation of a G(alpha s)-like protein by 5-HTdro1 but lack of coupling to inhibitory G-proteins by 5-HTdro2B. FEBS Lett. 381:1996;233-236.
118. Oksenberg D., Havlik S., Peroutka S.J., Ashkenazi A. The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificity. J. Neurochem. 64:1995;1440-1447.
119. Oksenberg D., Marsters S.A., O'Dowd B.F., Jin H., Havlik S., Peroutka S.J., Ashkenazi A. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature. 360:1992;161-163.
120. Panicker M.M., Parker I., Miledi R. Receptors of the serotonin 1C subtype expressed from cloned DNA mediate the closing of K+ membrane channels encoded by brain mRNA. Proc. Natl. Acad. Sci. USA. 88:1991;2560-2562.
121. Parker E.M., Grisel D.A., Iben L.G., Nowak H.P., Mahle C.D., Yocca F.D., Gaughan G.T. Characterization of human 5-HT1 receptors expressed in Sf9 insect cells. Eur. J. Pharmacol. 268:1994;43-53.
122. Parker E.M., Grisel D.A., Iben L.G., Shapiro R.A. A single amino acid difference accounts for the pharmacological difference between the rat and human 5-hydroxytryptamine1B receptors. J. Neurochem. 60:1993;380-383.
123. Pauwels P.J., Colpaert F.C. The 5-HT1D receptor antagonist GR 127,935 is an agonist at cloned human 5-HT1Dα receptor sites. Neuropharmacol. 34:1995;235-237.
124. Pauwels P.J., Palmier C., Wurch T., Colpaert F.C. Pharmacology of the cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: Further evidence differentiating human 5-HT1D and 5-HT1B receptors. Naunyn Schmiedebergs Arch. Pharmacol. 353:1996;144-156.
125. Pauwels P.J., Wurch T., Amoureux M.C., Palmier C., Colpaert F.C. Stimulation of cloned human serotonin 5-HT1D beta receptor sites in stably transfected C6 glial cells promotes cell growth. J. Neurochem. 66:1996;65-73.
126. Peroutka S.J. Pharmacological differentiation of human 5-HT1B and 5-HT1D receptors. Biol. Signals. 3:1994;217-222.
127. Plassat J.L., Amlaiky N., Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44:1993;229-236.
128. Plassat J.L., Boschert U., Amlaiky N., Hen R. The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J. 11:1992;4779-4786.
129. Pritchett D.B., Bach A.W., Wozny M., Taleb O., Dal Toso R., Shih J.C., Seeburg P.H. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J. 7:1988;4135-4140.
130. Quick M.W., Simon M.I., Davidson N., Lester H.A., Aragay A.M. Differential coupling of G protein alpha subunits to seven-helix receptors expressed in Xenopus oocytes. J. Biol. Chem. 269:1994;30164-30172.
131. Raymond J.R. J. Biol. Chem. 266:1991;14747-14753.
132. Raymond J.R., Albers F.J., Middleton J.P., Lefkowitz R.J., Caron M.G., Obeid L.M., Dennis V.W. 5-HT1A and histamine H1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools. J. Biol. Chem. 266:1991;372-379.
133. Raymond J.R., Fargin A., Middleton J.P., Graff J.M., Haupt D.M., Caron M.G., Lefkowitz R.J., Dennis V.W. The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C. J. Biol. Chem. 264:1989;21943-21950.
134. Raymond J.R., Olsen C.L., Gettys T.W. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein α subunits and lack of coupling to Gsα Biochemistry. 32:1993;11064-11073.
135. Rees S., Dendaas I., Foord S., Goodson S., Bull D., Kilpatrick G., Lee M. Cloning and characterisation of the human 5-HT5A serotonin receptor. FEBS Lett. 355:1994;242-246.
136. Roth B.L., Ciaranello R.D., Meltzer H.Y. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J. Pharmacol. Exp. Ther. 260:1992;1361-1365.
137. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.
138. Roth B.L., Palvimaki E.P., Berry S., Khan N., Sachs N., Uluer A., Choudhary M.S. 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J. Pharmacol. Exp. Ther. 275:1995;1638-1646.
139. Ruat M., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Diaz J., Leurs R., Schwartz J.C. A novel rat serotonin (5-HT6) receptor: Molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193:1993;268-276.
140. Ruat M., Traiffort E., Leurs R., Tardivel-Lacombe J., Diaz J., Arrang J.M., Schwartz J.C. Molecular cloning, characterization, and localization of a high- affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA. 90:1993;8547-8551.
141. Saltzman A.G., Morse B., Whitman M.M., Ivanshchenko Y., Jaye M., Felder S. Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem. Biophys. Res. Commun. 181:1991;1469-1478.
142. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 265:1994;1875-1878.
143. Saudou F., Boschert U., Amlaiky N., Plassat J.L., Hen R. A family of Drosophila serotonin receptors with distinct intracellular signalling properties and expression patterns. EMBO J. 11:1992;7-17.
144. Schmuck K., Ullmer C., Engels P., Lubbert H. Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett. 342:1994;85-90.
145. Schoeffter P., Ullmer C., Bobirnac I., Gabbiani G., Lubbert H. Functional, endogenously expressed 5-hydroxytryptamine 5-ht7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol. 117:1996;993-994.
146. Schoeffter P., Waeber C. Naunyn-Schmiedebergs Arch. Pharmacol. 350:1995;356-360.
147. Sealfon S.C., Chi L., Ebersole B.J., Rodic V., Zhang D., Ballesteros J.A., Weinstein H. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J. Biol. Chem. 270:1995;16683-16688.
148. Sebben M., Ansanay H., Bockaert J., Dumuis A. 5-HT receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuroreport. 5:1994;2553-2557.
149. Shen Y., Monsma F.J. Jr., Metcalf M.A., Jose P.A., Hamblin M.W., Sibley D.R. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268:1993;18200-18204.
150. Shichijo S., Payan D.G., Harrowe G., Mitsuhashi M. Histamine effects on the 5-HT1c receptor expressed in Xenopus oocytes. J. Neurosci. Res. 30:1991;316-320.
151. Sleight A.J., Stam N.J., Mutel V., Vanderheyden P.M.L. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities. Biochem. Pharmacol. 51:1996;71-76.
152. Stam N.J., van der Heyden P., van Alebeek C., Klomp J., de Boer T., van Delft A.M.L., Olijve W. Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT(2C) receptor. Eur. J. Pharmacol. 269:1994;339-348.
153. Stam N.J., Van Huizen F., Van Alebeek C., Brands J., Dijkema R., Tonnaer J.A., Olijve W. Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. Eur. J. Pharmacol. 227:1992;153-162.
154. Sugamori K.S., Sunahara R.K., Guan H.C., Bulloch A.G., Tensen C.P., Seeman P., Niznik H.B., Van Tol H.H. Serotonin receptor cDNA cloned from Lymnaea stagnalis. Proc. Natl. Acad. Sci. USA. 90:1993;11-15.
155. Szele F.G., Pritchett D.B. High affinity agonist binding to cloned 5-hydroxytryptamine2 receptors is not sensitive to GTP analogs. Mol. Pharmacol. 43:1993;915-920.
156. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 374:1995;542-546.
157. 3H ]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: Evidence for multiple states and not multiple 5HT2 receptor subtypes Mol. Pharmacol. 38:1990;594-598.
158. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
159. Tohda M., Tohda C., Oda H., Nomura Y. Possible involvement of botulinum ADP-ribosyltransferase sensitive low molecular G-protein on 5-hydroxytryptamine (5-HT)-induced inositol phosphates formation in 5-HT2c cDNA transfected cells. Neurosci. Lett. 190:1995;33-36.
160. Tsou A.P., Kosaka A., Bach C., Zuppan P., Yee C., Tom L., Alvarez R., Ramsey S., Bonhaus D.W., Stefanich E.et al. Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 63:1994;456-464.
161. Unsworth C.D., Molinoff P.B. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J. Pharmacol. Exp. Ther. 269:1994;246-255.
162. Van Huizen F., Bansse M.T., Stam N.J. Agonist-induced down-regulation of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells. Neuroreport. 4:1993;1327-3130.
163. Van Obberghen-Schilling E., Vouret-Craviari V., Haslam R.J., Chambard J.C., Pouyssegur J. Cloning, functional expression and role in cell growth regulation of a hamster 5-HT2 receptor subtype. Mol. Endocrinol. 5:1991;881-889.
164. van Sande J., Allgeier A., Massart C., Czernilofsky A., Vassart G., Dumont J.E., Maenhaut C. The human and dog 5-HT1D receptors can both activate and inhibit adenylate cyclase in transfected cells. Eur. J. Pharmacol. 247:1993;177-184.
165. Vanhoutte P.M., Humphrey P.P.A., Spedding M. X. International union of pharmacology recommendations for nomenclature of new receptor subtypes. Pharm. Rev. 48:1996;1-2.
166. Varrault A., Journot L., Audigier Y., Bockaert J. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: Effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase. Mol. Pharmacol. 41:1992;999-1007.
167. Veldman S.A., Bienkowski M.J. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype. Mol. Pharmacol. 42:1992;439-444.
168. Voigt M.M., Laurie D.J., Seeburg P.H., Bach A. Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. EMBO J. 10:1991;4017-4023.
169. Vouret-Craviari V., Auberger P., Pouyssegur J., Van Obberghen-Schilling E. Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J. Biol. Chem. 270:1995;4813-4821.
170. Wainscott D.B., Cohen M.L., Schenck K.W., Audia J.E., Nissen J.S., Baez M., Kursar J.D., Lucaites V.L., Nelson D.L. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor. Mol. Pharmacol. 43:1993;419-426.
171. Wainscott D.B., Lucaites V.L., Kursar J.D., Baez M., Nelson D.L. Pharmacologic characterization of the human 5-hydroxytryptamine(2B) receptor: Evidence for species differences. J. Pharmacol. Exp. Ther. 276:1996;720-727.
172. Wang H.Y., Eberle W.K., Simansky K.J., Friedman E. Serotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein. J. Pharmacol. Exp. Ther. 267:1993;1002-1011.
173. Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A., Hartig P.R. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. Proc. Natl. Acad. Sci. USA. 89:1992;3630-4363.
174. Weiss H.M., Haase W., Michel H., Reilander H. Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: Pharmacological characterization and localization. FEBS Lett. 377:1995;451-456.
175. Westphal R.S., Backstrom J.R., Sanders-Bush E. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 48:1995;200-205.
176. Westphal R.S., Sanders-Bush E. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol. Pharmacol. 46:1994;937-942.
177. Westphal R.S., Sanders-Bush E. Differences in agonist-independent and dependent 5-hydroxytryptamine2C receptor-mediated cell division. Mol. Pharmacol. 49:1996;474-480.
178. Weydert A., Cloez-Tayarani I., Fillion M.P., Simon-Chazottes D., Guenet J.L., Fillion G. Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig. Crit. Rev. Acad. Sci. III. 314:1992;429-435.
179. Wilkinson, L.O., Dourish, C.T., 1991. In: Peroutka, S. (Ed.), Serotonin Receptor Subtypes: Basic and Clinical Aspects. Wiley, New York, pp. 147-210.
180. Wisden W., Parker E.M., Mahle C.D., Grisel D.A., Nowak H.P., Yocca F.D., Felder C.C., Seeburg P.H., Voigt M.M. Cloning and characterization of the rat 5-HT5B receptor. Evidence that the 5-HT5B receptor couples to a G protein in mammalian cell membranes. FEBS Lett. 333:1993;25-31.
181. Witz P., Amlaiky N., Plassat J.L., Maroteaux L., Borrelli E., Hen R. Cloning and characterization of a Drosophila serotonin receptor that activates adenylate cyclase. Proc. Natl. Acad. Sci. USA. 87:1990;8940-8944.
182. Wurch T., Cathala C.C., Palmier C., Valentin J.P., John G.W., Colpaert F.C., Pauwels P.J. Molecular cloning and identification of a rabbit saphenous vein 5-HT1D-beta receptor gene. Neurosci. Res. Comm. 18:1996;155-162.
183. Yang W., Chen K., Lan N.C., Gallaher T.K., Shih J.C. Gene structure and expression of the mouse 5-HT2 receptor. J. Neurosci. Res. 33:1992;196-204.
184. Yu L., Nguyen H., Le H., Bloem L.J., Kozak C.A., Hoffman B.J., Snutch T.P., Lester H.A., Davidson N., Lubbert H. The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked. Brain Res. Mol. Brain Res. 11:1991;143-149.
185. Zgombick J.M., Borden L.A., Cochran T.L., Kucharewicz S.A., Weinshank R.L., Branchek T.A. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5- hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: Inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol. Pharmacol. 44:1993;575-582.
186. Zgombick J.M., Schechter L.E., Macchi M., Hartig P.R., Branchek T.A., Weinshank R.L. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor. Mol. Pharmacol. 42:1992;180-185.
187. Zgombick J.M., Weinshank R.L., Macchi M., Schechter L.E., Branchek T.A., Hartig P.R. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype. Mol. Pharmacol. 40:1991;1036-1042.
188. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.